In turn, a retrospective analysis of the VigiBase revealed 613 fatal ICI-associated toxic events, and among patients treated with anti-PD1/PD-L1 (n = 333), most of them had lung cancer: 152 (54%) [44]. The gene discussed is PDCD1; the disease is lung carcinoma.